Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Crossover Comparison of Two Formulations of Flutemetamol F 18 Injection
NCT07873463Phase 2Not yet recruiting
- Sponsor
- GE HealthCare
- Start
- Sep 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 2 trial of flutemetamol in cognitive dysfunction, sponsored by GE HealthCare. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
flutemetamol
03
Conditions
cognitive dysfunction
Beyond the preview
Go deeper on NCT07873463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07873463.